September 10, 2018
Researchers find unexpected cells at the centre of recurrent leukemia
Hamilton researchers discover that cancer stem cells may not be the only culprits of acute myeloid leukemia relapse
Although current chemotherapy for acute myeloid leukemia (AML) is effective in the short term, the disease often returns a few years after treatment. A new study suggests that the relapse of leukemia may not be caused by leukemic stem cells – a special set of cells that can avoid initial treatment by not dividing, then give rise to new cancerous cells after therapy – but rather a different class of leukemic cells.
Continue reading – Researchers find unexpected cells at the centre of recurrent leukemia
October 20, 2017
Old drug, new trick: study finds common diabetes drug could help fight leukemia
Researchers have discovered a new potential treatment for acute myeloid leukemia (AML). They found that boosting fat cells (adipocytes) within bone marrow with the use of a common diabetes drug slowed the growth of cancerous cells and promoted the regeneration of healthy blood cells.
Continue reading – Old drug, new trick: study finds common diabetes drug could help fight leukemia
